Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation
- 1 June 2016
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 1 (3) , 366-8
Abstract
Research from JAMA Cardiology — Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial FibrillationKeywords
This publication has 3 references indexed in Scilit:
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet, 2014
- Adaptation and validation of the Charlson Index for Read/OXMIS coded databasesBMC Family Practice, 2010
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 2007